This phase I trial tests the safety and effectiveness of 18F-TRX in detecting tumors (cancer) patients with solid tumors. 18F-TRX is an imaging tracer that is used to visualize tumors using a PET scan. It specifically targets and detects labile (unstable) iron levels within tissues, including tumors. Diagnostic procedures, such as 18F-TRX PET/CT or PET/MRI, may help detect tumors in patients with solid tumors
Phase:
PHASE1
Details
Lead Sponsor:
Rahul Aggarwal
Collaborator:
United States Department of Defense
Treatments:
Biopsy Blood Specimen Collection Magnetic Resonance Spectroscopy Specimen Handling